Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Oct 4, 2010 at 7:49 AM EDT

Big Risks in Genzyme As Sanofi-Aventis Bid Goes Hostile (GENZ, SNY)

The Sanofi-Aventis (NYSE: SNY) acquisition attempt of Genzyme Corp. (NASDAQ: GENZ) is taking a turn in a strange direction. The…

Jon C. Ogg | Oct 1, 2010 at 11:03 AM EDT

Healthcare Reform Watch: Wal-Mart, Humana, and Low-Cost Drug Insurance (WMT, HUM, TGT, WAG, CVS, RAD)

Wal-Mart Stores Inc. (NYSE: WMT) has just pumped up the pressure on its competitors in the pharmacy business. The retailing…

Jon C. Ogg | Sep 29, 2010 at 8:02 AM EDT

Genzyme Set For Higher Bid? (GENZ, SNY)

The proposed merger and acquisition of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) is about to get interesting. There…

Douglas A. McIntyre | Sep 24, 2010 at 5:18 AM EDT

The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future

Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007…

Douglas A. McIntyre | Sep 10, 2010 at 6:04 PM EDT

Genzyme, Buy-Out Target, Makes Mass Layoffs: National Employee Morale Day

Genzyme (NASDAQ: GENZ), the target of a buyout offer from Sanofi-Aventis, began to lay-off almost 10% of its workforce today.…

Jon C. Ogg | Sep 9, 2010 at 1:57 PM EDT

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…

Douglas A. McIntyre | Sep 3, 2010 at 4:45 AM EDT

Family Healthcare Costs Rise, But Workers Pay For The Increase

Family health premiums rose 3% to $13,770. this year. The number seems modest but it is not for those who…

Jon C. Ogg | Aug 21, 2010 at 1:04 PM EDT

The Unusual Suspects For The Week Ahead (APOL, AUO, BKS, BHP, POT, BP, CPIX, FISV, GENZ, JAZZ, NFLX, NOVL, SYMC, TYC, VRML, CALL)

There are many issues to watch in the coming week for this weekend’s edition of THE UNUSUAL SUSPECTS. We have…

Jon C. Ogg | Aug 9, 2010 at 8:01 AM EDT

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY)…

Douglas A. McIntyre | Aug 5, 2010 at 4:34 AM EDT

The Obesity Index: The Cost of Obesity by State

Health care costs for treating obesity-related illness are as high as $149 billion per year, according to a report released…

Douglas A. McIntyre | Aug 4, 2010 at 12:10 PM EDT

As J&J Faces Crisis, Questions Arise About Board’s Role

This has been a year to forget for Johnson & Johnson (NYSE: JNJ). Unfortunately for shareholders, the company’s board appears…

Jon C. Ogg | Aug 3, 2010 at 9:48 AM EDT

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a…

Jon C. Ogg | Aug 3, 2010 at 7:41 AM EDT

Pfizer Earnings Meet Dirt Cheap Valuations (PFE)

Pfizer Inc. (NYSE: PFE) is out with earnings of $0.62 EPS on an adjusted basis on 58% growth in revenues…

Douglas A. McIntyre | Aug 3, 2010 at 5:19 AM EDT

Allergan: The Power Of Botox

Allergan (NYSE: AGN) announced its second quarter earnings and a dividend of $.05 a share. The company can afford it.…

Jon C. Ogg | Jul 27, 2010 at 12:51 PM EDT

Boston Scientific’s New Stent May Assist in Turnaround (BSX, ABT, JNJ, MDT, STJ)

Boston Scientific Corporation (NYSE: BSX) has been a long and painful investment for thousands of shareholders who have held shares…

1 … 330 331 332 333 334 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Big Risks in Genzyme As Sanofi-Aventis Bid Goes Hostile (GENZ, SNY)

Healthcare Reform Watch: Wal-Mart, Humana, and Low-Cost Drug Insurance (WMT, HUM, TGT, WAG, CVS, RAD)

Genzyme Set For Higher Bid? (GENZ, SNY)

The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future

Genzyme, Buy-Out Target, Makes Mass Layoffs: National Employee Morale Day

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Family Healthcare Costs Rise, But Workers Pay For The Increase

The Unusual Suspects For The Week Ahead (APOL, AUO, BKS, BHP, POT, BP, CPIX, FISV, GENZ, JAZZ, NFLX, NOVL, SYMC, TYC, VRML, CALL)

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

The Obesity Index: The Cost of Obesity by State

As J&J Faces Crisis, Questions Arise About Board’s Role

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

Pfizer Earnings Meet Dirt Cheap Valuations (PFE)

Allergan: The Power Of Botox

Boston Scientific’s New Stent May Assist in Turnaround (BSX, ABT, JNJ, MDT, STJ)

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

Health and Healthcare Articles

All Health and Healthcare Articles

Big Risks in Genzyme As Sanofi-Aventis Bid Goes Hostile (GENZ, SNY)

Healthcare Reform Watch: Wal-Mart, Humana, and Low-Cost Drug Insurance (WMT, HUM, TGT, WAG, CVS, RAD)

Genzyme Set For Higher Bid? (GENZ, SNY)

The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future

Genzyme, Buy-Out Target, Makes Mass Layoffs: National Employee Morale Day

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Family Healthcare Costs Rise, But Workers Pay For The Increase

The Unusual Suspects For The Week Ahead (APOL, AUO, BKS, BHP, POT, BP, CPIX, FISV, GENZ, JAZZ, NFLX, NOVL, SYMC, TYC, VRML, CALL)

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

The Obesity Index: The Cost of Obesity by State

As J&J Faces Crisis, Questions Arise About Board’s Role

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

Pfizer Earnings Meet Dirt Cheap Valuations (PFE)

Allergan: The Power Of Botox

Boston Scientific’s New Stent May Assist in Turnaround (BSX, ABT, JNJ, MDT, STJ)

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal